Unexplained weight loss (UWL) remains a clinical conundrum, often signaling underlying systemic disorders. It is incumbent upon clinicians to adopt a comprehensive approach to this multifaceted issue.
UWL is typically defined as a loss of more than 5% of body weight over a period of 6-12 months without a clear etiology. It's a common symptom in various diseases, including malignancies, endocrine disorders, gastrointestinal diseases, and psychiatric conditions.
History-taking and physical examination are paramount in the initial evaluation. The former should focus on dietary habits, gastrointestinal symptoms, changes in taste or smell, and medication use. The latter should be comprehensive, with particular attention to signs of cachexia, lymphadenopathy, and abdominal masses.
Initial laboratory investigations should include complete blood count, metabolic panel, liver function tests, thyroid function tests, and inflammatory markers. If these are inconclusive, imaging studies, endoscopy, and biopsy may be warranted. It's crucial to consider the patient's age, associated symptoms, and risk factors while planning the diagnostic approach.
Management should be etiology-specific and may involve treating the underlying disease, nutritional support, or pharmacotherapy. In cases where no clear cause is found, a symptom-based approach, regular follow-up, and reassessment are essential.
UWL is a complex clinical entity that requires a comprehensive, patient-centered approach. A meticulous history, thorough physical examination, and judicious use of diagnostic tests are key to identifying the underlying cause. Management should be tailored to the specific etiology, with a focus on addressing the patient's symptoms and improving their quality of life.
1.
High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy
2.
Papillary thyroid cancer: New markers offer hope for tailored treatment
3.
What Comes After Cancer?
4.
FDA Expands Durvalumab Label to Operable Lung Cancer
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Finding Support: Connecting with the Vitiligo Community
2.
Essential Updates in Hematology in Daily Practice
3.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
4.
Living Better With Advanced Cancer Through Supportive Care
5.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
2.
Updates on Standard V/S High Risk Myeloma Treatment
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation